Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure

Schizophrenia Bulletin

Volumn 38, Issue 6, 2012, Pages 1149-1154

  Bamne, Mikhil ^a   Wood, Joel ^a   Chowdari, Kodavali ^a   Watson, Annie M ^a   Celik, Cemil ^b   Mansour, Hader ^a   Klei, Lambertus ^a   Gur, Ruben C ^c   Bradford, L Dianne ^d   Calkins, Monica E ^c   Santos, Alberto B ^e   Edwards, Neil ^f   Kwentus, Joseph ^g   McEvoy, Joseph P ^c   Allen, Trina B ^d   Savage, Robert M ^h   Nasrallah, Henry A ⁱ   Gur, Raquel E ^j   Perry, Rodney T ^c   Go, Rodney C P ^k   Devlin, Bernie ^k   Yolken, Robert ^a   Nimgaonkar, Vishwajit L ^l,m   more..

^a UNIVERSITY OF PITTSBURGH   (United States)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

^m JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

African American; cytomegalovirus; gene; HLA; HSV 1; schizophrenia

Indexed keywords

HLA ANTIGEN;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HERPES SIMPLEX VIRUS 1; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TOXOPLASMA GONDII;

ADULT; AFRICAN AMERICANS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 6; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HLA ANTIGENS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA; TOXOPLASMOSIS, CEREBRAL;

EID: 84869066703     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs087     Document Type: Article

References (30)

1. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;460:753-757.
2. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460: 744-747.
3. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
4. Steinberg S, de Jong S, Andreassen OA, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet. 2011;20(20):4076-4081.
5. Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43:969-976.
6. Wright P, Nimgaonkar VL, Donaldson PT, Murray RM. Schizophrenia and HLA: a review. Schizophr Res. 2001;47:1-12.
7. Nimgaonkar VL, Ganguli R, Rudert WA, Vavassori C, Rabin BS, Trucco M. A negative association of schizophrenia with an allele of the HLA DQB1 gene among African-Americans. Schizophrenia Res. 1992;8:199-209.
8. Nimgaonkar VL, Ganguli R, Rudert WA, Vavassori C, Rabin BS, Trucco M. A negative association of schizophrenia with an allele of the HLA DQB1 gene among African-Americans. Schizophr Res. 1993;8:199-209.
9. Nimgaonkar VL, Rudert WA, Zhang XR, Tsoi WF, Trucco M, Saha N. Further evidence for an association between schizophrenia and the HLA DQB1 gene locus. Schizophr Res. 1995;18:43-49.
10. Kim JJ, Shirts BH, Dayal M, et al. Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia? Ann Med. 2007;39:145-153.
11. Shirts BH, Kim JJ, Reich S, et al. Polymorphisms in MICB are associated with human herpes virus seropositivity and schizophrenia risk. Schizophr Res. 2007;94:342-353.
12. Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry. 2008;13(5):470-479.
13. DeLisi LE. A critical overview of recent investigations into the genetics of schizophrenia. Curr opin Psychiatr. 1999;12:29-39.
14. Pedersen MG, Stevens H, Pedersen CB, Nørgaard-Pedersen B, Mortensen PB. Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry. 2011;168:814-821.
15. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondij in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2007;33:729-736.
16. Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res. 2008;106:268-274.
17. Aliyu MH, Calkins ME, Swanson CL Jr, et al. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods. Schizophr Res. 2006;87:32-44.
18. Calkins ME, Tepper P, Gur RC, et al. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. Am J Psychiatry. 2010;167:459-472.
19. Wiener H, Klei L, Calkins M, et al. Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects [published online ahead of print January 10, 2012]. Schizophr Bull. doi: 10.1093/ schbul/sbr161
20. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet. 2006;79:640-649.
21. Ashley RL, Wu L, Pickering JW, Tu MC, Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol. 1998;36:294-295.
22. Shirts BH, Wood J, Yolken RH, Nimgaonkar VL. Association study of IL10, IL1?, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1?. Schizophr Res. 2006;88:235-244.
23. Pasaniuc B, Sankararaman S, Kimmel G, Halperin E. Inference of locus-specific ancestry in closely related populations. Bioinformatics. 2009;25:i213-i221.
24. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry. 2003;60: 466-472.
25. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54:1046-1054.
26. Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 2003;34:2126-2131.
27. Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res. 2011;128(1-3):61-65.
28. Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL. Exposure to Herpes Simplex Virus Type 1 and cognitive impairments in individuals with schizophrenia [published online ahead of print April 6, 2012]. Schizophr Bull. doi:10.1093/schbul/sbs046
29. Albrecht P, Torrey EF, Boone E, Hicks JT, Daniel N. Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet. 1980;2:769-772.
30. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci. 2005;46:241-247.